Cargando…

Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis

BACKGROUND: Bronchodilators administered through inhalation devices are the mainstay treatment for patients with obstructive lung diseases. Patients do not view devices as interchangeable. This systematic review and meta-analysis examined device feature preferences among patients with obstructive lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Navaie, Maryam, Dembek, Carole, Cho-Reyes, Soojin, Yeh, Karen, Celli, Bartolome R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310962/
https://www.ncbi.nlm.nih.gov/pubmed/32569208
http://dx.doi.org/10.1097/MD.0000000000020718
_version_ 1783549466362511360
author Navaie, Maryam
Dembek, Carole
Cho-Reyes, Soojin
Yeh, Karen
Celli, Bartolome R.
author_facet Navaie, Maryam
Dembek, Carole
Cho-Reyes, Soojin
Yeh, Karen
Celli, Bartolome R.
author_sort Navaie, Maryam
collection PubMed
description BACKGROUND: Bronchodilators administered through inhalation devices are the mainstay treatment for patients with obstructive lung diseases. Patients do not view devices as interchangeable. This systematic review and meta-analysis examined device feature preferences among patients with obstructive lung diseases treated with handheld inhalers. STUDY APPRAISAL AND SYNTHESIS METHODS: PubMed, EMBASE, PsycINFO, Cochrane, and Google Scholar were searched to identify publications between 2010 and 2019 that met the following criteria: (1).. English language; (2).. studied adults with chronic obstructive pulmonary disease, bronchitis, or emphysema; and (3).. reported patients’ device feature preferences specific to metered-dose inhalers, dry powder inhalers, and soft mist inhalers. A manual search extended the study period from 2001 to 2019. Random-effects models were used to generate pooled mean effect sizes and 95% confidence intervals (CIs) for preferred device features. Heterogeneity was measured by the I(2) statistic. RESULTS: Nineteen studies (n = 11,256) were included in this meta-analysis. Average age ranged from 50.4 to 74.3 years. The majority of patients were male (57%) and had chronic obstructive pulmonary disease (92%). Patients preferred the following device features: (1).. small size (71.7%, 95% CI: 46.3, 97.1; n = 604, 3 studies); (2).. rapid medication administration (64.9%, 95% CI: 36.5, 93.4; n = 745, 3 studies); (3).. durability (62.1%, 95% CI: 39.7, 84.4; n = 4,500, 4 studies); (4).. a dose counter (52.3%, 95% CI: 20.7, 83.9; n = 4,536, 4 studies); (5).. portability (51.8%, 95% CI: 29.1, 74.5; n = 4,975, 7 studies); (6).. perceived ease of use (51.2%, 95% CI: 35.6, 66.7; n = 5,878, 10 studies); and (7).. perceived ease of dose preparation (50.1%, 95% CI: 26.2, 73.9; n = 4,003, 4 studies). CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: Adults with obstructive lung diseases preferred small inhaler devices that were portable, durable, perceived as easy to use, and fast in medication administration. Healthcare providers should give due consideration to the patient's device feature preferences when developing a treatment plan that prescribes an inhalation device.
format Online
Article
Text
id pubmed-7310962
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-73109622020-07-08 Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis Navaie, Maryam Dembek, Carole Cho-Reyes, Soojin Yeh, Karen Celli, Bartolome R. Medicine (Baltimore) 6700 BACKGROUND: Bronchodilators administered through inhalation devices are the mainstay treatment for patients with obstructive lung diseases. Patients do not view devices as interchangeable. This systematic review and meta-analysis examined device feature preferences among patients with obstructive lung diseases treated with handheld inhalers. STUDY APPRAISAL AND SYNTHESIS METHODS: PubMed, EMBASE, PsycINFO, Cochrane, and Google Scholar were searched to identify publications between 2010 and 2019 that met the following criteria: (1).. English language; (2).. studied adults with chronic obstructive pulmonary disease, bronchitis, or emphysema; and (3).. reported patients’ device feature preferences specific to metered-dose inhalers, dry powder inhalers, and soft mist inhalers. A manual search extended the study period from 2001 to 2019. Random-effects models were used to generate pooled mean effect sizes and 95% confidence intervals (CIs) for preferred device features. Heterogeneity was measured by the I(2) statistic. RESULTS: Nineteen studies (n = 11,256) were included in this meta-analysis. Average age ranged from 50.4 to 74.3 years. The majority of patients were male (57%) and had chronic obstructive pulmonary disease (92%). Patients preferred the following device features: (1).. small size (71.7%, 95% CI: 46.3, 97.1; n = 604, 3 studies); (2).. rapid medication administration (64.9%, 95% CI: 36.5, 93.4; n = 745, 3 studies); (3).. durability (62.1%, 95% CI: 39.7, 84.4; n = 4,500, 4 studies); (4).. a dose counter (52.3%, 95% CI: 20.7, 83.9; n = 4,536, 4 studies); (5).. portability (51.8%, 95% CI: 29.1, 74.5; n = 4,975, 7 studies); (6).. perceived ease of use (51.2%, 95% CI: 35.6, 66.7; n = 5,878, 10 studies); and (7).. perceived ease of dose preparation (50.1%, 95% CI: 26.2, 73.9; n = 4,003, 4 studies). CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: Adults with obstructive lung diseases preferred small inhaler devices that were portable, durable, perceived as easy to use, and fast in medication administration. Healthcare providers should give due consideration to the patient's device feature preferences when developing a treatment plan that prescribes an inhalation device. Wolters Kluwer Health 2020-06-19 /pmc/articles/PMC7310962/ /pubmed/32569208 http://dx.doi.org/10.1097/MD.0000000000020718 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 6700
Navaie, Maryam
Dembek, Carole
Cho-Reyes, Soojin
Yeh, Karen
Celli, Bartolome R.
Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
title Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
title_full Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
title_fullStr Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
title_full_unstemmed Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
title_short Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
title_sort inhaler device feature preferences among patients with obstructive lung diseases: a systematic review and meta-analysis
topic 6700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310962/
https://www.ncbi.nlm.nih.gov/pubmed/32569208
http://dx.doi.org/10.1097/MD.0000000000020718
work_keys_str_mv AT navaiemaryam inhalerdevicefeaturepreferencesamongpatientswithobstructivelungdiseasesasystematicreviewandmetaanalysis
AT dembekcarole inhalerdevicefeaturepreferencesamongpatientswithobstructivelungdiseasesasystematicreviewandmetaanalysis
AT choreyessoojin inhalerdevicefeaturepreferencesamongpatientswithobstructivelungdiseasesasystematicreviewandmetaanalysis
AT yehkaren inhalerdevicefeaturepreferencesamongpatientswithobstructivelungdiseasesasystematicreviewandmetaanalysis
AT cellibartolomer inhalerdevicefeaturepreferencesamongpatientswithobstructivelungdiseasesasystematicreviewandmetaanalysis